Cargando…

Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report

INTRODUCTION: Systemic mastocystosis, a disorder of clonal mast cell expansion presents with symptoms of flushing, pruritus, musculoskeletal pain, gastrointestinal cramping and vascular instability. Patients with neuroendocrine tumors may present with similar symptoms due to the release of vasoactiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacco, Keith, Khan, Tahsin M., Passi, Monica, Hernandez, Jonathan M., Komarow, Hirsh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688994/
https://www.ncbi.nlm.nih.gov/pubmed/33220657
http://dx.doi.org/10.1016/j.ijscr.2020.11.028
_version_ 1783613769151152128
author Sacco, Keith
Khan, Tahsin M.
Passi, Monica
Hernandez, Jonathan M.
Komarow, Hirsh
author_facet Sacco, Keith
Khan, Tahsin M.
Passi, Monica
Hernandez, Jonathan M.
Komarow, Hirsh
author_sort Sacco, Keith
collection PubMed
description INTRODUCTION: Systemic mastocystosis, a disorder of clonal mast cell expansion presents with symptoms of flushing, pruritus, musculoskeletal pain, gastrointestinal cramping and vascular instability. Patients with neuroendocrine tumors may present with similar symptoms due to the release of vasoactive mediators in both diseases. We report the co-occurrence of systemic mastocytosis and a neuroendocrine pancreatic tumor for which the patient received disease-specific treatment. CASE PRESENTATION: A 58-year-old woman with a history of indolent systemic mastocytosis and a serum tryptase of 51 ng/mL was diagnosed with a solid pancreatic lesion on ultrasound when assessing for organomegaly. Lesional biopsy was consistent with a pancreatic neuroendocrine tumor which was successfully resected. DISCUSSION: Presenting symptoms such as skin rashes, flushing, fatigue and diarrhea, are similar for systemic mastocytosis and neuroendocrine tumors. The co-occurrence of both diseases has not been previously reported. Activating mutations in KIT, which are a hallmark of systemic mastocytosis, may drive neoplastic proliferation in neuroendocrine tumors. Furthermore, mast cells infiltrating pancreatic tissue may have a trophic effect on the development of pancreatic neuroendocrine tumors. CONCLUSION: While challenging to diagnose both diseases presenting with similar symptoms, recognition of these distinct diseases is necessary to ensure timely treatment.
format Online
Article
Text
id pubmed-7688994
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-76889942020-12-07 Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report Sacco, Keith Khan, Tahsin M. Passi, Monica Hernandez, Jonathan M. Komarow, Hirsh Int J Surg Case Rep Case Report INTRODUCTION: Systemic mastocystosis, a disorder of clonal mast cell expansion presents with symptoms of flushing, pruritus, musculoskeletal pain, gastrointestinal cramping and vascular instability. Patients with neuroendocrine tumors may present with similar symptoms due to the release of vasoactive mediators in both diseases. We report the co-occurrence of systemic mastocytosis and a neuroendocrine pancreatic tumor for which the patient received disease-specific treatment. CASE PRESENTATION: A 58-year-old woman with a history of indolent systemic mastocytosis and a serum tryptase of 51 ng/mL was diagnosed with a solid pancreatic lesion on ultrasound when assessing for organomegaly. Lesional biopsy was consistent with a pancreatic neuroendocrine tumor which was successfully resected. DISCUSSION: Presenting symptoms such as skin rashes, flushing, fatigue and diarrhea, are similar for systemic mastocytosis and neuroendocrine tumors. The co-occurrence of both diseases has not been previously reported. Activating mutations in KIT, which are a hallmark of systemic mastocytosis, may drive neoplastic proliferation in neuroendocrine tumors. Furthermore, mast cells infiltrating pancreatic tissue may have a trophic effect on the development of pancreatic neuroendocrine tumors. CONCLUSION: While challenging to diagnose both diseases presenting with similar symptoms, recognition of these distinct diseases is necessary to ensure timely treatment. Elsevier 2020-11-10 /pmc/articles/PMC7688994/ /pubmed/33220657 http://dx.doi.org/10.1016/j.ijscr.2020.11.028 Text en © 2020 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Sacco, Keith
Khan, Tahsin M.
Passi, Monica
Hernandez, Jonathan M.
Komarow, Hirsh
Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report
title Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report
title_full Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report
title_fullStr Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report
title_full_unstemmed Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report
title_short Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report
title_sort pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688994/
https://www.ncbi.nlm.nih.gov/pubmed/33220657
http://dx.doi.org/10.1016/j.ijscr.2020.11.028
work_keys_str_mv AT saccokeith pancreaticneuroendocrinetumorpresentinginindolentsystemicmastocytosisacasereport
AT khantahsinm pancreaticneuroendocrinetumorpresentinginindolentsystemicmastocytosisacasereport
AT passimonica pancreaticneuroendocrinetumorpresentinginindolentsystemicmastocytosisacasereport
AT hernandezjonathanm pancreaticneuroendocrinetumorpresentinginindolentsystemicmastocytosisacasereport
AT komarowhirsh pancreaticneuroendocrinetumorpresentinginindolentsystemicmastocytosisacasereport